Internal Server Error

David Ross - portfolio and founded companies

Last updated:

About David Ross

David Ross is an entrepreneur, an angel investor and a board member. They did their education from Stanford. Their journey in the startup ecosystem started in 1994 through Tissuemed. David Ross has founded 1 company. They are currently acting as the, and as the co-founder of Alitheon. As an angel investor, David Ross has a portfolio of 4 companies, focusing primarily on sectors like Enterprise Applications, High Tech and 7 more sectors. They invest in companies across United Kingdom and New Zealand. Their most notable investments include companies like Stubben Edge and HydrOxSys. David Ross is currently serving as a board member at Alitheon and Exsurgo, which they founded. In the past, they have acted as a board member of Tissuemed.
Key Metrics
Founded
Board Memberships
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Contact Details

David Ross' Investments

David Ross has invested in 4 companies, which was in Helico (Seed Round) on May 18, 2022. Their investments are primarily in Enterprise Applications, High Tech and 7 more sectors. Their investment portfolio include companies in United Kingdom and New Zealand.
Here is the detail of this recent investment:
Date
Company
Round
Round Amount
Co-Investors
May 18, 2022
Seed
$1.26M
View all Investments by David Ross
Want to explore profiles similar to David Ross?
Let us walk you through our investor database and other offerings.

David Ross' Founded Companies

David Ross has founded Alitheon.
Here is the detail of this founded company:
Company
Short Description
Total Funding
Founded Year
Current Stage
Location
Provider of AI and cloud-based object identification technology
$40.9M
2015
Series A
Bellevue
View all Founded Companies by David Ross

David Ross' Board Memberships

David Ross has 2 current and 1 past board memberships including Alitheon and Tissuemed.
Here are the details of all board memberships by David Ross:
Company
Description
Total Funding
Current Stage
Membership Status
Appointment Date
Cessation Date
Provider of AI and cloud-based object identification technology
$40.9M
Series A
CURRENT
Jun 06, 2017
-
Bioadhesive films to prevent body fluid and air leakage during surgery
$12.7M
Acqui-Hired
PAST
Nov 07, 1994
Jul 03, 1997
View all Board Memberships of David Ross

FAQs about David Ross

Recently updated other profiles
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford